Quarterly report · Q2
3604.TEDINET S100SAC7
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥30.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥100m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥279m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥218m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥825m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥341m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥289m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥338m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥179m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥747m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥217m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥208m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥222m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥19.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥19.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥17.0bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.0bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥12.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥866m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥339m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥175m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥62m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥205m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥705m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥122m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥858m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥223m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥30.84 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.47 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.46 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.32 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment ordinary income | 2023-04-01 → 2023-09-30 | −¥294m |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥10.5bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥389m |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥123m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥512m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-04-01 → 2022-09-30 | −¥244m |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| jpcrp040300-q2r_E00614-000Consumerreportable segment | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥449m |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E00614-000Medicalreportable segment | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥136m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥15.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥15.1bn |
| Total Of Reportable Segments And Otherssegment total | segment ordinary income | 2022-04-01 → 2022-09-30 | ¥585m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -8772000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -15148000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 124037000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 94117000 | JPY |
| Comprehensive income | Prior1YTDDuration | 346477000 | JPY |
| Comprehensive income | CurrentYTDDuration | 302050000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 341125000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 272844000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 5352000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 29206000 | JPY |
| Income before income taxes | Prior1YTDDuration | 337647000 | JPY |
| Income before income taxes | CurrentYTDDuration | 288731000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 105046000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 122825000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 16613000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 16930000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 2643000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -406000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -7780000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -10065000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 8091000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 12565000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -25120000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -63061000 | JPY |
| Loss gain on sales and retirement of noncurrent assets ope cf | Prior1YTDDuration | 81000 | JPY |
| Loss gain on sales and retirement of noncurrent assets ope cf | CurrentYTDDuration | -581000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -42922000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 38557000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -51670000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | 268886000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -197883000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 72399000 | JPY |
| Increase decrease in refund liabilities ope cf | Prior1YTDDuration | -13526000 | JPY |
| Increase decrease in refund liabilities ope cf | CurrentYTDDuration | -25417000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -8892000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -39549000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | Prior1YTDDuration | 4003000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | CurrentYTDDuration | -186922000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | -22297000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | -39168000 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YTDDuration | 53708000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | 32807000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -9345000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -33971000 | JPY |
| Decrease increase in other assets ope cf | Prior1YTDDuration | 35372000 | JPY |
| Decrease increase in other assets ope cf | CurrentYTDDuration | -7389000 | JPY |
| Increase decrease in other liabilities ope cf | Prior1YTDDuration | -1589000 | JPY |
| Increase decrease in other liabilities ope cf | CurrentYTDDuration | -36049000 | JPY |
| Other net ope cf | Prior1YTDDuration | -66066000 | JPY |
| Other net ope cf | CurrentYTDDuration | 111595000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |